| 1 |
33761503 | Successful Multimodality Management of Atypical Teratoid/Rhabdoid Tumour of the Lower Dorsal Spine with Spinal Drop Metastasis: Illustrated Review. | 2021 |
1 |
| 2 |
34329577 | Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study. | 2021 Aug |
1 |
| 3 |
32006654 | Aldehyde dehydrogenase 3A1 confers oxidative stress resistance accompanied by altered DNA damage response in human corneal epithelial cells. | 2020 Apr |
1 |
| 4 |
32945942 | Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities. | 2020 Nov |
1 |
| 5 |
33121007 | Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study. | 2020 Oct 27 |
2 |
| 6 |
31122751 | [Primary central nervous system lymphoma following immunotherapy for metastatic melanoma]. | 2019 Oct |
1 |
| 7 |
28208865 | Adult Neuroblastoma-Case Report and Literature Review. | 2016 Dec |
1 |
| 8 |
26221234 | Promising response of anaplastic lymphoma kinase-positive large B-cell lymphoma to crizotinib salvage treatment: case report and review of literature. | 2015 |
1 |
| 9 |
26365969 | Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas. | 2015 Sep 20 |
2 |
| 10 |
26374553 | Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer. | 2015 Nov |
1 |
| 11 |
24944079 | Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation. | 2014 Dec |
2 |
| 12 |
22525550 | Emergency hemicolectomy for intestinal primary aspergillosis in acute myeloid leukemia. | 2012 Mar |
1 |
| 13 |
22099936 | Did salvage ICE chemotherapy improve the outcome in primary resistant/relapsing stage III/IV neuroblastoma? | 2011 Mar |
1 |
| 14 |
19701081 | High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphoma. | 2010 Jan |
1 |
| 15 |
18573848 | Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system. | 2008 Jul |
1 |
| 16 |
16702184 | Pretreatment prognostic factors and outcome in patients with relapsed or primary-refractory diffuse large B-cell lymphoma treated with second-line chemotherapy and autologous stem cell transplantation. | 2006 May |
1 |
| 17 |
15287915 | ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience. | 2004 Sep |
2 |
| 18 |
12736226 | Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma. | 2003 |
1 |
| 19 |
12042984 | Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. | 2002 May |
1 |
| 20 |
12215019 | Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases. | 2002 Aug |
1 |
| 21 |
12803126 | Severe hyperglycemia as a complication of big ICE chemotherapy in a patient with acute myeloblastic leukemia. | 2002 |
1 |
| 22 |
11589488 | Three conventional-drug combination (ifosfamide, carboplatin, etoposide--ICE regimen) in advanced non-small cell lung cancer (NSCLC). | 2001 Aug |
1 |
| 23 |
10642996 | [A successfully operated case of choriocarcinoma with recurrent intratumoral hemorrhage]. | 2000 Jan |
1 |
| 24 |
10216478 | High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer. | 1999 Jan-Feb |
1 |
| 25 |
10577849 | Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. | 1999 Dec |
1 |
| 26 |
9876059 | Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC). | 1998 Dec |
2 |
| 27 |
9885442 | Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma. | 1998 Dec |
2 |
| 28 |
9329558 | Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status. | 1997 Jul-Aug |
1 |
| 29 |
8677446 | Dose-intensive ifosfamide for the treatment of non-Hodgkin's lymphoma. | 1996 Jun |
1 |
| 30 |
8677454 | Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study. | 1996 Jun |
1 |
| 31 |
8899175 | The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease. | 1996 Sep |
1 |
| 32 |
7602350 | Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study. | 1995 Jul |
1 |
| 33 |
7610396 | Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide. | 1995 Jun |
1 |
| 34 |
7610397 | Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer. | 1995 Jun |
1 |
| 35 |
7610398 | Ifosfamide/carboplatin/etoposide chemotherapy for metastatic breast cancer with or without autologous hematopoietic stem cell transplantation: evaluation of dose-response relationships. | 1995 Jun |
1 |
| 36 |
7758997 | Remission induction therapy for adults with acute myelogenous leukemia: towards the ICE age? | 1995 Jan-Feb |
1 |